HRT Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
151,706
+92,142
| +155% | +$6.36M | 0.05% | 231 |
|
|
2025
Q1 | $4.14M | Buy |
59,564
+10,089
| +20% | +$701K | 0.03% | 432 |
|
|
2024
Q4 | $4.26M | Buy |
+49,475
| New | +$4.26M | 0.02% | 368 |
|
|
2022
Q2 | – | Sell |
-4,768
| Closed | -$264K | – | 3300 |
|
|
2022
Q1 | $264K | Sell |
4,768
-29,094
| -86% | -$1.61M | ﹤0.01% | 2085 |
|
|
2021
Q4 | $1.9M | Sell |
33,862
-37,076
| -52% | -$2.08M | 0.01% | 612 |
|
|
2021
Q3 | $3.41M | Buy |
+70,938
| New | +$3.41M | 0.02% | 426 |
|
|
2021
Q2 | – | Sell |
-71,390
| Closed | -$2.41M | – | 3154 |
|
|
2021
Q1 | $2.41M | Buy |
71,390
+47,208
| +195% | +$1.59M | 0.02% | 448 |
|
|
2020
Q4 | $844K | Buy |
+24,182
| New | +$844K | 0.02% | 721 |
|
|
2019
Q2 | – | Sell |
-11,900
| Closed | -$311K | – | 839 |
|
|
2019
Q1 | $311K | Buy |
+11,900
| New | +$311K | 0.05% | 257 |
|